Regulation of BRCA1 Transcription by Specific Single-Stranded DNA Binding Factors

REFERENCES

• Anderson, P. 1995. TIA-1: structural and functional studies on a new class of cytolytic effector molecule. Curr. Top. Microbiol. Immunol. 198: 131–143.
   PubMedGoogle Scholar
• Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl. 1996. DNA protein interactions, p. 2.12.1-2.12.11. Current protocols in molecular biology. John Wiley and Sons, Inc., New York, N.Y.
   Google Scholar
• Baldwin, R. L., E. Nemeth, H. Tran, H. Shvartsman, I. Cass, S. Narod, and B. Y. Karlan. 2000. BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study. Cancer Res. 60: 5329–5333.
   PubMed Web of Science ®Google Scholar
• Bazar, L., D. Meighen, V. Harris, R. Duncan, D. Levens, and M. Avigan. 1995. Targeted melting and binding of a DNA regulatory element by a transactivator of c-Myc. J. Biol. Chem. 270: 8241–8248.
   PubMedGoogle Scholar
• Beger, C., L. N. Pierce, M. Kruger, E. G. Marcusson, J. M. Robbins, P. Welcsh, P. J. Welch, K. Welte, M. C. King, J. R. Barber, and F. Wong-Staal. 2001. Identification of Id4 as a regulator of BRCA1 expression by using a ribozyme-library-based inverse genomics approach. Proc. Natl. Acad. Sci. USA 98: 130–135.
   PubMed Web of Science ®Google Scholar
• Bianco, T., G. Chenevix-Trench, D. C. Walsh, J. E. Cooper, and A. Dobrovic. 2000. Tumour-specific distribution of BRCA1 promoter region methylation supports a pathogenetic role in breast and ovarian cancer. Carcinogenesis 21: 147–151.
   PubMedGoogle Scholar
• Brown, M. A., H. Nicolai, C. F. Xu, B. L. Griffiths, K. A. Jones, E. Solomon, L. Hosking, J. Trowsdale, D. M. Black, and R. McFarlane. 1994. Regulation of BRCA1. Nature 372: 733.
   PubMedGoogle Scholar
• Brown, M. A., C. F. Xu, H. Nicolai, B. Griffiths, J. A. Chambers, D. Black, and E. Solomon. 1996. The 5′ end of the BRCA1 gene lies within a duplicated region of human chromosome 17q21. Oncogene 12: 2507–2513.
   PubMedGoogle Scholar
• Burd, C. G., M. S. Swanson, M. Gorlach, and G. Dreyfuss. 1989. Primary structures of the heterogeneous nuclear ribonucleoprotein A2, B1, and C2 proteins: a diversity of RNA binding proteins is generated by small peptide inserts. Proc. Natl. Acad. Sci. USA 86: 9788–9792.
   PubMed Web of Science ®Google Scholar
• Catteau, A., W. H. Harris, C. F. Xu, and E. Solomon. 1999. Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics. Oncogene 18: 1957–1965.
   PubMed Web of Science ®Google Scholar
• Czyzyk-Krzeska, M. F., and J. E. Beresh. 1996. Characterization of the hypoxia-inducible protein binding site within the pyrimidine-rich tract in the 3′-untranslated region of the tyrosine hydroxylase mRNA. J. Biol. Chem. 271: 3293–3299.
   PubMedGoogle Scholar
• Davis-Smyth, T., R. C. Duncan, T. Zheng, G. Michelotti, and D. Levens. 1996. The far upstream element-binding proteins comprise an ancient family of single-strand DNA-binding transactivators. J. Biol. Chem. 271: 31679–31687.
   PubMedGoogle Scholar
• Dobrovic, A., and D. Simpfendorfer. 1997. Methylation of the BRCA1 gene in sporadic breast cancer. Cancer Res. 57: 3347–3350.
   PubMed Web of Science ®Google Scholar
• Duncan, R., L. Bazar, G. Michelotti, T. Tomonaga, H. Krutzsch, M. Avigan, and D. Levens. 1994. A sequence-specific, single-strand binding protein activates the far upstream element of c-myc and defines a new DNA-binding motif. Genes Dev. 8: 465–480.
   PubMedGoogle Scholar
• Esteller, M., J. M. Silva, G. Dominguez, F. Bonilla, X. Matias-Guiu, E. Lerma, E. Bussaglia, J. Prat, I. C. Harkes, E. A. Repasky, E. Gabrielson, M. Schutte, S. B. Baylin, and J. G. Herman. 2000. Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J. Natl. Cancer Inst. 92: 564–569.
   PubMed Web of Science ®Google Scholar
• Fearon, E. R. 2000. BRCA1 and E-cadherin promoter hypermethylation and gene inactivation in cancer-association or mechanism? J. Natl. Cancer Inst. 92: 515–517.
   PubMedGoogle Scholar
• Futreal, P. A., Q. Liu, D. Shattuck-Eidens, C. Cochran, K. Harshman, S. Tavtigian, L. M. Bennett, A. Haugen-Strano, J. Swensen, Y. Miki, et al. 1994. BRCA1 mutations in primary breast and ovarian carcinomas. Science 266: 120–122.
   PubMed Web of Science ®Google Scholar
• Gil, A., P. A. Sharp, S. F. Jamison, and M. A. Garcia-Blanco. 1991. Characterization of cDNAs encoding the polypyrimidine tract-binding protein. Genes Dev. 5: 1224–1236.
   PubMed Web of Science ®Google Scholar
• Gudas, J. M., T. Li, H. Nguyen, D. Jensen, F. J. Rauscher, III, and K. H. Cowan. 1996. Cell cycle regulation of BRCA1 messenger RNA in human breast epithelial cells. Cell Growth Differ. 7: 717–723.
   PubMedGoogle Scholar
• Kumar, A., K. R. Williams, and W. Szer. 1986. Purification and domain structure of core hnRNP proteins A1 and A2 and their relationship to single-stranded DNA-binding proteins. J. Biol. Chem. 261: 11266–11273.
   PubMedGoogle Scholar
• Lane, T. F., C. Deng, A. Elson, M. S. Lyu, C. A. Kozak, and P. Leder. 1995. Expression of Brca1 is associated with terminal differentiation of ectodermally and mesodermally derived tissues in mice. Genes Dev. 9: 2712–2722.
   PubMed Web of Science ®Google Scholar
• Lao, Y., C. G. Lee, and M. S. Wold. 1999. Replication protein A interactions with DNA. 2. Characterization of double-stranded DNA-binding/helix-destabilization activities and the role of the zinc-finger domain in DNA interactions. Biochemistry 38: 3974–3984.
   PubMed Web of Science ®Google Scholar
• Liu, J., S. Akoulitchev, A. Weber, H. Ge, S. Chuikov, D. Libutti, X. W. Wang, J. W. Conaway, C. C. Harris, R. C. Conaway, D. Reinberg, and D. Levens. 2001. Defective interplay of activators and repressors with TFIH in xeroderma pigmentosum. Cell 104: 353–363.
   PubMedGoogle Scholar
• Liu, J., L. He, I. Collins, H. Ge, D. Libutti, J. Li, J. M. Egly, and D. Levens. 2000. The FBP interacting repressor targets TFIIH to inhibit activated transcription. Mol. Cell 5: 331–341.
   PubMed Web of Science ®Google Scholar
• Ma, W. J., S. Cheng, C. Campbell, A. Wright, and H. Furneaux. 1996. Cloning and characterization of HuR, a ubiquitously expressed Elav-like protein. J. Biol. Chem. 271: 8144–8151.
   PubMed Web of Science ®Google Scholar
• Magdinier, F., L. M. Billard, G. Wittmann, L. Frappart, M. Benchaib, G. M. Lenoir, J. F. Guerin, and R. Dante. 2000. Regional methylation of the 5′ end CpG island of BRCA1 is associated with reduced gene expression in human somatic cells. FASEB J. 14: 1585–1594.
   PubMedGoogle Scholar
• Magdinier, F., S. Ribieras, G. M. Lenoir, L. Frappart, and R. Dante. 1998. Down-regulation of BRCA1 in human sporadic breast cancer; analysis of DNA methylation patterns of the putative promoter region. Oncogene 17: 3169–3176.
   PubMedGoogle Scholar
• Mancini, D. N., D. I. Rodenhiser, P. J. Ainsworth, F. P. O'Malley, S. M. Singh, W. Xing, and T. K. Archer. 1998. CpG methylation within the 5′ regulatory region of the BRCA1 gene is tumor specific and includes a putative CREB binding site. Oncogene 16: 1161–1169.
   PubMed Web of Science ®Google Scholar
• Manley, J. L., A. Fire, A. Cano, P. A. Sharp, and M. L. Gefter. 1980. DNA-dependent transcription of adenovirus genes in a soluble whole-cell extract. Proc. Natl. Acad. Sci. USA 77: 3855–3859.
   PubMed Web of Science ®Google Scholar
• Marquis, S. T., J. V. Rajan, A. Wynshaw-Boris, J. Xu, G. Y. Yin, K. J. Abel, B. L. Weber, and L. A. Chodosh. 1995. The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues. Nat. Genet. 11: 17–26.
   PubMed Web of Science ®Google Scholar
• Matunis, M. J., W. M. Michael, and G. Dreyfuss. 1992. Characterization and primary structure of the poly(C)-binding heterogeneous nuclear ribonucleoprotein complex K protein. Mol. Cell. Biol. 12: 164–171.
   PubMed Web of Science ®Google Scholar
• Miki, Y., J. Swensen, D. Shattuck-Eidens, P. A. Futreal, K. Harshman, S. Tavtigian, Q. Liu, C. Cochran, L. M. Bennett, W. Ding, et al. 1994. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266: 66–71.
   PubMed Web of Science ®Google Scholar
• Murakami, Y., and Y. Ito. 1999. Transcription factors in DNA replication. Front. Biosci. 4: D824–D833.
   PubMedGoogle Scholar
• Niwa, Y., T. Oyama, and T. Nakajima. 2000. BRCA1 expression status in relation to DNA methylation of the BRCA1 promoter region in sporadic breast cancers. Jpn. J. Cancer Res. 91: 519–526.
   PubMedGoogle Scholar
• Patton, J. G., S. A. Mayer, P. Tempst, and B. Nadal-Ginard. 1991. Characterization and molecular cloning of polypyrimidine tract-binding protein: a component of a complex necessary for pre-mRNA splicing. Genes Dev. 5: 1237–1251.
   PubMed Web of Science ®Google Scholar
• Rice, J. C., and B. W. Futscher. 2000. Transcriptional repression of BRCA1 by aberrant cytosine methylation, histone hypoacetylation and chromatin condensation of the BRCA1 promoter. Nucleic Acids Res. 28: 3233–3239.
   PubMedGoogle Scholar
• Rice, J. C., K. S. Massey-Brown, and B. W. Futscher. 1998. Aberrant methylation of the BRCA1 CpG island promoter is associated with decreased BRCA1 mRNA in sporadic breast cancer cells. Oncogene 17: 1807–1812.
   PubMedGoogle Scholar
• Rice, J. C., H. Ozcelik, P. Maxeiner, I. Andrulis, and B. W. Futscher. 2000. Methylation of the BRCA1 promoter is associated with decreased BRCA1 mRNA levels in clinical breast cancer specimens. Carcinogenesis 21: 1761–1765.
   PubMed Web of Science ®Google Scholar
• Rustighi, A., M. A. Tessari, F. Vascotto, R. Sgarra, V. Giancotti, and G. Manfioletti. 2002. A polypyrimidine/polypurine tract within the Hmga2 minimal promoter: a common feature of many growth-related genes. Biochemistry 41: 1229–1240.
   PubMed Web of Science ®Google Scholar
• Sattin, R. W., G. L. Rubin, L. A. Webster, C. M. Huezo, P. A. Wingo, H. W. Ory, and P. M. Layde. 1985. Family history and the risk of breast cancer. JAMA 253: 1908–1913.
   PubMed Web of Science ®Google Scholar
• Stucki, M., I. Stagljar, Z. O. Jonsson, and U. Hubscher. 2000. A coordinated interplay: proteins with multiple functions in DNA replication, DNA repair, cell cycle/checkpoint control, and transcription. Prog. Nucleic Acid Res. Mol. Biol. 65: 261–298.
   Google Scholar
• Suen, T. C., and P. E. Goss. 1999. Transcription of BRCA1 is dependent on the formation of a specific protein-DNA complex on the minimal BRCA1 bi-directional promoter. J. Biol. Chem. 274: 31297–31304.
   PubMedGoogle Scholar
• Tay, N., S. H. Chan, and E. C. Ren. 1992. Identification and cloning of a novel heterogeneous nuclear ribonucleoprotein C-like protein that functions as a transcriptional activator of the hepatitis B virus enhancer II. J. Virol. 66: 6841–6848.
   PubMedGoogle Scholar
• Thakur, S., and C. M. Croce. 1999. Positive regulation of the BRCA1 promoter. J. Biol. Chem. 274: 8837–8843.
   PubMedGoogle Scholar
• Thakur, S., H. C. Lin, W. T. Tseng, S. Kumar, R. Bravo, F. Foss, C. Gelinas, and A. B. Rabson. 1994. Rearrangement and altered expression of the NFKB-2 gene in human cutaneous T-lymphoma cells. Oncogene 9: 2335–2344.
   PubMed Web of Science ®Google Scholar
• Thakur, S., H. B. Zhang, Y. Peng, H. Le, B. Carroll, T. Ward, J. Yao, L. M. Farid, F. J. Couch, R. B. Wilson, and B. L. Weber. 1997. Localization of BRCA1 and a splice variant identifies the nuclear localization signal. Mol. Cell. Biol. 17: 444–452.
   PubMed Web of Science ®Google Scholar
• Thompson, M. E., R. A. Jensen, P. S. Obermiller, D. L. Page, and J. T. Holt. 1995. Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nat. Genet. 9: 444–450.
   PubMed Web of Science ®Google Scholar
• Tommerup, N., and H. Leffers. 1996. Assignment of human KH-box-containing genes by in situ hybridization: HNRNPK maps to 9q21.32-q21.33, PCBP1 to 2p12-p13, and PCBP2 to 12q13.12-q13.13, distal to FRA12A. Genomics 32: 297–298.
   PubMedGoogle Scholar
• Tsui, S., T. Dai, S. Roettger, W. Schempp, E. C. Salido, and P. H. Yen. 2000. Identification of two novel proteins that interact with germ-cell-specific RNA-binding proteins DAZ and DAZL1. Genomics 65: 266–273.
   PubMedGoogle Scholar
• Wilson, C. A., L. Ramos, M. R. Villasenor, K. H. Anders, M. F. Press, K. Clarke, B. Karlan, J. J. Chen, R. Scully, D. Livingston, R. H. Zuch, M. H. Kanter, S. Cohen, F. J. Calzone, and D. J. Slamon. 1999. Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas. Nat. Genet. 21: 236–240.
   PubMed Web of Science ®Google Scholar
• Wold, M. S. 1997. Replication protein A: a heterotrimeric, single-stranded DNA-binding protein required for eukaryotic DNA metabolism. Annu. Rev. Biochem. 66: 61–92.
   PubMed Web of Science ®Google Scholar
• Xu, C. F., M. A. Brown, J. A. Chambers, B. Griffiths, H. Nicolai, and E. Solomon. 1995. Distinct transcription start sites generate two forms of BRCA1 mRNA. Hum. Mol. Genet. 4: 2259–2264.
   PubMed Web of Science ®Google Scholar